Maybe they think you've been ramping too much.
in their defense, looking at it from a lay perspective, this isn't entirely relevant to our core strategy ie cancer(I realise it further reaffirms FTO in a human's overall disease process). And it isn't a new finding per se, as we know zantrene and FTO is linked(twice already independently).
While I agree it further reaffirms the Zantrene and FTO link, from what I can see, diabetes isn't on the cards for any clinical trials. A lot of posters here have been prematurely excited off this paper, but there is still a lot of work to be done before there would be a tangible return, IMO.
with that said, you did say you deemed it as not price sensitive, so I'm not sure how it's ramping.
This from a non scientific POV, Dr T.. I'm happy for you to correct me if you think otherwise.
Maybe they think you've been ramping too much .in their defense,...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.180(11.5%) |
Mkt cap ! $296.8M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.80 | $1.58 | $772.4K | 450.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2354 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.76 | 525 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.75 |
Change
0.180 ( 11.2 %) |
||||
| Open | High | Low | Volume | ||
| $1.60 | $1.80 | $1.58 | 22024 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| RAC (ASX) Chart |